Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host–Pathogen Interactions
Open Access
- 29 June 2023
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 13 (7) , 1060
Abstract
The significance of internal mRNA modifications for the modulation of transcript stability, for regulation of nuclear export and translation efficiency, and their role in suppressing innate immunity is well documented. Over the years, the molecular complexes involved in the dynamic regulation of the most prevalent modifications have been characterized—we have a growing understanding of how each modification is set and erased, where it is placed, and in response to what cues. Remarkably, internal mRNA modifications, such as methylation, are emerging as an additional layer of regulation of immune cell homeostasis, differentiation, and function. A fascinating recent development is the investigation into the internal modifications of host/pathogen RNA, specifically N6-methyladenosine (m6A), its abundance and distribution during infection, and its role in disease pathogenesis and in shaping host immune responses. Low molecular weight compounds that target RNA-modifying enzymes have shown promising results in vitro and in animal models of different cancers and are expanding the tool-box in immuno-oncology. Excitingly, such modulators of host mRNA methyltransferase or demethylase activity hold profound implications for the development of new broad-spectrum therapeutic agents for infectious diseases as well. This review describes the newly uncovered role of internal mRNA modification in infection and in shaping the function of the immune system in response to invading pathogens. We will also discuss its potential as a therapeutic target and identify pitfalls that need to be overcome if it is to be effectively leveraged against infectious agents.Keywords
Funding Information
- Institut Pasteur (ACIP 328-20)
This publication has 91 references indexed in Scilit:
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- Gene-expression profiling of Gram-positive and Gram-negative sepsis in critically ill patients*Critical Care Medicine, 2008
- Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNAImmunity, 2005
- Anti‐HIV‐1 activity of 3‐deaza‐adenosine analogsEuropean Journal of Biochemistry, 2003
- Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains.Proceedings of the National Academy of Sciences, 1995
- Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton ratsAntiviral Research, 1990
- Specific inhibition of the synthesis of influenza virus late proteins and stimulation of early, M2, and NS2 protein synthesis by 3-deazaadenosineVirology, 1990
- Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosineAntiviral Research, 1983
- 3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of rous sarcoma virus and transformation of chick embryo cellsVirology, 1978
- The methylated constituents of L cell messenger RNA: Evidence for an unusual cluster at the 5′ terminusCell, 1975